| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| eFFECTOR Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 150,000 | 20 Jan 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919122004683-patel-premal-2022-01-20 | eFFECTOR Therapeutics, Inc. | 20 Jan 2022 | 1 | $0 | 4 | Chief Medical Officer | 24 Jan 2022, 19:05 |
| /report/000120919121053702-patel-premal-2021-08-25 | eFFECTOR Therapeutics, Inc. | 25 Aug 2021 | 2 | $0 | 4 | Chief Medical Officer | 27 Aug 2021, 18:19 |
| /report/000120919121053700-patel-premal-2021-08-25 | eFFECTOR Therapeutics, Inc. | 25 Aug 2021 | 0 | $0 | 3 | Chief Medical Officer | 27 Aug 2021, 18:16 |